Antimicrobials are used to treat infections and are an asset to human and animal health and calls for prudent use to maintain its efficacy. Globally, only 50% of antibiotics are being used correctly and if left unchecked, the World Bank projects that the AMR crisis could negatively impact global Gross Domestic Product (GDP) with reduction as large as the one provoked by the 2008 global financial crisis. However, those in low and middle-income countries would be most affected and driving more people into poverty. A virtual event organized a day before WAAW 2020 by the Livestock Antimicrobial Partnership (LAMP)-network hosted by the Swedish University of Agricultural Sciences (SLU), was attended by nearly 250 participants, and included distinguished speakers from the World Bank, International Livestock Research Institute (ILRI) and World Organisation for Animal Health (OIE), Food Agriculture Organization of the United Nations (FAO), SLU and Vétérinaires Sans Frontières International.
The CGIAR Antimicrobial Resistance Hub, which is hosted and led by the International Livestock Research Institute (ILRI) is working the International Food Policy Research Institute (IFPRI), World Fish and the International Water Management Institute (IWMI) to address agricultural-associated antimicrobial resistance (AMR) in low- and middle-income countries (LMICs). The research is largely supported by the CGIAR Research Program (CPR) on Agriculture for Nutrition and Health (A4NH) as well as Livestock and Fish CRPs. Projects undertaken in Africa and Asia aim to reduce the burden of agriculture associated AMR.
The CGIAR Antimicrobial Resistance Hub, led by the International Livestock Research Institute (ILRI), applies a One Health approach to support the efforts of low- and middle-income countries (LMICs) in controlling agriculture-associated AMR risks, through promoting and facilitating transdisciplinary partnerships.
The recently adopted CGIAR AMR strategy recognizes the need for evidence on links between agriculture (crops, livestock and aquaculture) and public health outcomes. Based on evidence generated, the hub develops solutions that are locally relevant and applicable, while being adaptable to other contexts.
We conduct context-driven and systems-oriented research that combines social and biological sciences. With AMR research in agriculture and aquaculture and understanding linkages to public health outcomes, we can reap solutions emerging from our transdisciplinary approach.
We aim to reduce and refine AMU in agriculture and aquaculture and its impact on the environment, and to facilitate evidence-based communication around agriculture-associated AMR. This will help to mitigate AMR risks for people and contributes to improving the sustainability of global food and health systems.
The implementation framework of our strategy is organized into five pillars.
Judiciously addressing antimicrobial resistance is especially important in low- and middle-income countries, where poverty exacerbates cycles of inequity
Tackling antimicrobial resistance helps sustain small-scale agriculture and aquaculture and improve poor people’s access to nourishing food
Particularly in poorer countries already facing a high disease burden, antimicrobial resistance increases the likelihood that medical and veterinary treatments will fail
The problem of antimicrobial resistance can exacerbate gender inequality by increasing the risks faced by female primary caregivers of contracting antimicrobial-resistant infections
Over- and misuse of antibiotics and other antimicrobial drugs can contaminate soil and water resources, endangering people’s access to safe drinking water
It has been estimated that if not stemmed, antimicrobial resistance could cost the global economy up to USD100 trillion by 2050
Rational use of antibiotics and other antimicrobial drugs in good animal and fish husbandry practices is key to safeguarding the longer-term effectiveness of these important drugs
Only large networks of interdisciplinary partnerships and collaborators will be able to meet the many challenges presented by the growing development of antimicrobial resistance